Pathological sections of 20 ovarian cancer specimens with complete clinical data showed that there were significant differences in lymph node metastasis and staging of ovarian cancer by the International Federation of Gynecology and Obstetrics (FIGO) between the high expression group and the low expression group of TAMs specific molecular marker CD68 [80]. Here, CD68 is linked to ovarian cancer.